The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment

被引:26
|
作者
Jia, Wentao [1 ]
Liang, Shufang [2 ]
Cheng, Binbin [1 ]
Ling, Changquan [1 ]
机构
[1] Naval Med Univ, Sch Tradit Chinese Med, Shanghai, Peoples R China
[2] Navy Med Univ, Changhai Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
基金
中国国家自然科学基金;
关键词
cancer-associated fibroblasts (CAFs); traditional Chinese medicine; hepatocellular carcinoma (HCC); stromal cell; tumor recurrence; HEPATIC STELLATE CELLS; GINKGO-BILOBA EXTRACT; ATTENUATES LIVER FIBROSIS; TISSUE GROWTH-FACTOR; GENE-EXPRESSION; LIPID DROPLETS; PPAR-GAMMA; STEM-CELLS; RAT-LIVER; KAPPA-B;
D O I
10.3389/fonc.2021.763519
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Invasion and metastasis are the main reasons for the high mortality of liver cancer, which involve the interaction of tumor stromal cells and malignant cells. Cancer-associated fibroblasts (CAFs) are one of the major constituents of tumor stromal cells affecting tumor growth, invasion, and metastasis. The heterogeneous properties and sources of CAFs make both tumor-supporting and tumor-suppression effects possible. The mechanisms for CAFs in supporting hepatocellular carcinoma (HCC) progression can be categorized into upregulated aggressiveness and stemness, transformed metabolism toward glycolysis and glutamine reductive carboxylation, polarized tumor immunity toward immune escape of HCC cells, and increased angiogenesis. The tumor-suppressive effect of fibroblasts highlights the functional heterogenicity of CAF populations and provides new insights into tumor-stromal interplay mechanisms. In this review, we introduced several key inflammatory signaling pathways in the transformation of CAFs from normal stromal cells and the heterogeneous biofunctions of activated CAFs. In view of the pleiotropic regulation properties of traditional Chinese medicine (TCM) and heterogeneous effects of CAFs, we also introduced the application and values of TCM in the treatment of HCC through targeting CAFs.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma
    Akkiz, Hikmet
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [2] Cancer-associated fibroblasts in hepatocellular carcinoma
    Kubo, Norio
    Araki, Kenichiro
    Kuwano, Hiroyuki
    Shirabe, Ken
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (30) : 6841 - 6850
  • [3] Cancer-associated fibroblasts in hepatocellular carcinoma
    Norio Kubo
    Kenichiro Araki
    Hiroyuki Kuwano
    Ken Shirabe
    World Journal of Gastroenterology, 2016, (30) : 6841 - 6850
  • [4] Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma
    Ying, Fan
    Chan, Mandy Sze Man
    Lee, Terence Kin Wah
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2023, 15 (04): : 985 - 999
  • [5] Traditional Chinese medicine as complementary treatment for hepatocellular carcinoma
    Jiao Kede
    Bie Limei
    Yin XiLing
    Yu Liqiu
    ETHIOPIAN JOURNAL OF HEALTH DEVELOPMENT, 2021, 35 (04)
  • [6] Identifying cancer-associated fibroblasts as emerging targets for hepatocellular carcinoma
    Jie Zhang
    Chaoyu Gu
    Qianqian Song
    Mengqi Zhu
    Yuqing Xu
    Mingbing Xiao
    Wenjie Zheng
    Cell & Bioscience, 10
  • [7] Identifying cancer-associated fibroblasts as emerging targets for hepatocellular carcinoma
    Zhang, Jie
    Gu, Chaoyu
    Song, Qianqian
    Zhu, Mengqi
    Xu, Yuqing
    Xiao, Mingbing
    Zheng, Wenjie
    CELL AND BIOSCIENCE, 2020, 10 (01):
  • [8] Role of exosomes in hepatocellular carcinoma and the regulation of traditional Chinese medicine
    Yao, Man
    Liang, Shufang
    Cheng, Binbin
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [9] Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma
    Xi, Sheng-Yan
    Minuk, Gerald Yosel
    WORLD JOURNAL OF HEPATOLOGY, 2018, 10 (11) : 799 - 806
  • [10] Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma
    Sheng-Yan Xi
    Gerald Yosel Minuk
    World Journal of Hepatology, 2018, (11) : 799 - 806